Literature DB >> 30078221

Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.

Silvia Caggia1, HimaBindu Chunduri1, Ana C Millena1, Jonathan N Perkins1, Smrruthi V Venugopal1, BaoHan T Vo2, Chunliang Li2, Yaping Tu3, Shafiq A Khan1.   

Abstract

Tumor cell motility is the essential step in cancer metastasis. Previously, we showed that oxytocin and epidermal growth factor (EGF) effects on cell migration in prostate cancer cells require Giα2 protein. In the current study, we investigated the interactions among G-protein coupled receptor (GPCR), Giα2, PI3-kinase, and Rac1 activation in the induction of migratory and invasive behavior by diverse stimuli. Knockdown and knockout of endogenous Giα2 in PC3 cells resulted in attenuation of transforming growth factor β1 (TGFβ1), oxytocin, SDF-1α, and EGF effects on cell migration and invasion. In addition, knockdown of Giα2 in E006AA cells attenuated cell migration and overexpression of Giα2 in LNCaP cells caused significant increase in basal and EGF-stimulated cell migration. Pretreatment of PC3 cells with Pertussis toxin resulted in attenuation of TGFβ1- and oxytocin-induced migratory behavior and PI3-kinase activation without affecting EGF-induced PI3-kinase activation and cell migration. Basal- and EGF-induced activation of Rac1 in PC3 and DU145 cells were not affected in cells after Giα2 knockdown. On the other hand, Giα2 knockdown abolished the migratory capability of PC3 cells overexpressing constitutively active Rac1. The knockdown or knockout of Giα2 resulted in impaired formation of lamellipodia at the leading edge of the migrating cells. We conclude that Giα2 protein acts at two different levels which are both dependent and independent of GPCR signaling to induce cell migration and invasion in prostate cancer cells and its action is downstream of PI3-kinase-AKT-Rac1 axis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  F-actin; G-protein coupled receptors; epidermal growth factor; lamellipodia; migration

Mesh:

Substances:

Year:  2018        PMID: 30078221      PMCID: PMC6202161          DOI: 10.1002/jcp.26894

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  52 in total

Review 1.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

Review 2.  Chemotaxis: signalling the way forward.

Authors:  Peter J M Van Haastert; Peter N Devreotes
Journal:  Nat Rev Mol Cell Biol       Date:  2004-08       Impact factor: 94.444

3.  EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein.

Authors:  Hiromichi Fujino; John W Regan
Journal:  Mol Pharmacol       Date:  2005-10-04       Impact factor: 4.436

4.  mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.

Authors:  XianGuo Chen; HaiYan Cheng; TengFei Pan; Yi Liu; Yang Su; CuiPing Ren; DaKe Huang; XiaoJun Zha; ChaoZhao Liang
Journal:  Mol Carcinog       Date:  2014-07-07       Impact factor: 4.784

Review 5.  PI3K and cancer: lessons, challenges and opportunities.

Authors:  David A Fruman; Christian Rommel
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

Review 6.  Rho GTPases in cancer cell biology.

Authors:  Francisco M Vega; Anne J Ridley
Journal:  FEBS Lett       Date:  2008-05-05       Impact factor: 4.124

7.  Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration.

Authors:  Kisha A Scarlett; El-Shaddai Z White; Christopher J Coke; Jada R Carter; Latoya K Bryant; Cimona V Hinton
Journal:  Mol Cancer Res       Date:  2018-01-12       Impact factor: 5.852

8.  Ethnic differences in TGFβ-signaling pathway may contribute to prostate cancer health disparity.

Authors:  Bethtrice Elliott; DeAdra L Zackery; Vanessa A Eaton; Re'Josef T Jones; Fisseha Abebe; Camille C Ragin; Shafiq A Khan
Journal:  Carcinogenesis       Date:  2018-04-05       Impact factor: 4.944

Review 9.  Role of Rho GTPases and their regulators in cancer progression.

Authors:  Rajamani Rathinam; Allison Berrier; Suresh K Alahari
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01

10.  Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.

Authors:  Pamela J Maxwell; Jessica Neisen; Johanna Messenger; David J J Waugh
Journal:  Oncotarget       Date:  2014-07-15
View more
  7 in total

1.  Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.

Authors:  Bethtrice Elliott; Ana Cecilia Millena; Lilya Matyunina; Mengnan Zhang; Jin Zou; Guangdi Wang; Qiang Zhang; Nathan Bowen; Vanessa Eaton; Gabrielle Webb; Shadyra Thompson; John McDonald; Shafiq Khan
Journal:  Cancer Lett       Date:  2019-02-11       Impact factor: 8.679

2.  Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells.

Authors:  Smrruthi Vaidegi Venugopal; Silvia Caggia; DaJhnae Gambrell-Sanders; Shafiq A Khan
Journal:  Prostate       Date:  2020-01-29       Impact factor: 4.104

Review 3.  Coordination between Rac1 and Rab Proteins: Functional Implications in Health and Disease.

Authors:  Azzurra Margiotta; Cecilia Bucci
Journal:  Cells       Date:  2019-04-29       Impact factor: 6.600

4.  Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT.

Authors:  Yan-Yan Zhao; Jing Jia; Jing-Jing Zhang; Yan-Ping Xun; Shu-Jun Xie; Jia-Feng Liang; Hong-Gang Guo; Jia-Zhen Zhu; Sheng-Lin Ma; Shi-Rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2020-11-06       Impact factor: 7.169

5.  Small Molecule Inhibitors Targeting Gαi2 Protein Attenuate Migration of Cancer Cells.

Authors:  Silvia Caggia; Subhasish Tapadar; Bocheng Wu; Smrruthi V Venugopal; Autumn S Garrett; Aditi Kumar; Janae S Stiffend; John S Davis; Adegboyega K Oyelere; Shafiq A Khan
Journal:  Cancers (Basel)       Date:  2020-06-19       Impact factor: 6.575

Review 6.  Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment.

Authors:  Lionel Larribère; Jochen Utikal
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

Review 7.  Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer.

Authors:  Ching-Hung Hsieh; Cheng-Zhe Jian; Liang-In Lin; Guan-Sian Low; Ping-Yun Ou; Chiun Hsu; Da-Liang Ou
Journal:  Cancers (Basel)       Date:  2022-01-07       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.